title: Regulatory watch: Innovative drug availability in China.
authors.affiliation: Fudan Center for Study of Pharmaceuticals and Healthcare Strategy and the School of Pharmacy, Fudan University, 826 Zhangheng Road, Zhangjiang Hi-tech Park, Pudong, Shanghai 201203, China.
authors.forename: Liming
authors.initials: L
authors.lastname: Shao
authors.affiliation: Fudan Center for Study of Pharmaceuticals and Healthcare Strategy, 826 Zhangheng Road, Zhangjiang Hi-tech Park, Pudong, Shanghai 201203, China.
authors.forename: Lili
authors.initials: L
authors.lastname: Xu
authors.affiliation: Fudan Center for Study of Pharmaceuticals and Healthcare Strategy, 826 Zhangheng Road, Zhangjiang Hi-tech Park, Pudong, Shanghai 201203, China.
authors.forename: Qiu
authors.initials: Q
authors.lastname: Li
authors.affiliation: Tufts Center for the Study of Drug Development (CSDD), Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
authors.forename: Ranjana
authors.initials: R
authors.lastname: Chakravarthy
authors.affiliation: Tufts Center for the Study of Drug Development (CSDD), Tufts University School of Medicine, Boston, Massachusetts 02111, USA.|Tufts CSDD in 2015.
authors.forename: Ziling
authors.initials: Z
authors.lastname: Yang
authors.affiliation: Tufts Center for the Study of Drug Development (CSDD), Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
authors.forename: Kenneth I
authors.initials: KI
authors.lastname: Kaitin
mesh_terms: D002681:China; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence* / Q000639:trends; D006801:Humans; D009936:Organizational Innovation; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence* / Q000639:trends